Cumberland Partners LTD Bausch Health Companies Inc. Transaction History

Cumberland Partners LTD

  • $1.26 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 07, 2020
SELL
$18.89 - $31.89 $245,570 - $414,570
-13,000 Closed
0 $0
Q3 2019

Nov 13, 2019
SELL
$20.88 - $25.66 $60,552 - $74,414
-2,900 Reduced 18.24%
13,000 $284,000
Q2 2019

Aug 08, 2019
BUY
$20.52 - $26.45 $326,268 - $420,555
15,900 New
15,900 $402,000

Others Institutions Holding BHC

# of Institutions
275
Shares Held
279M
Call Options Held
5.68M
Put Options Held
17.4M
View Full List

About Bausch Health Companies Inc.

BHC Quotes by TradingView
  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.95B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Cumberland Partners LTD Portfolio

Follow Cumberland Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cumberland Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Cumberland Partners LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email